…
Patient-centered Management of Advanced CSCC in the Evolving Era of Immunotherapy: Patients Speak: The CSCC Patient Journey
Cutaneous squamous cell carcinoma (CSCC) is the second most common type of skin cancer. For patients with advanced CSCC, treatment with immune checkpoint inhibitors such as cemiplimab and …